433 related articles for article (PubMed ID: 28391412)
1. Role of MiRNAs in Inflammatory Bowel Disease.
Cao B; Zhou X; Ma J; Zhou W; Yang W; Fan D; Hong L
Dig Dis Sci; 2017 Jun; 62(6):1426-1438. PubMed ID: 28391412
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs in inflammatory bowel disease: What do we know and what can we expect?
de Oliveira ECS; Quaglio AEV; Grillo TG; Di Stasi LC; Sassaki LY
World J Gastroenterol; 2024 Apr; 30(16):2184-2190. PubMed ID: 38690020
[TBL] [Abstract][Full Text] [Related]
3. Dynamic changes in extracellular vesicle-associated miRNAs elicited by ultrasound in inflammatory bowel disease patients.
Tran F; Scharmacher A; Baran N; Mishra N; Wozny M; Chavez SP; Bhardwaj A; Hinz S; Juzenas S; Bernardes JP; Sievers LK; Lessing M; Aden K; Lassen A; Bergfeld A; Weber HJ; Neas L; Vetrano S; Schreiber S; Rosenstiel P
Sci Rep; 2024 May; 14(1):10925. PubMed ID: 38740826
[TBL] [Abstract][Full Text] [Related]
4. Exploring potential biomarkers and therapeutic targets in inflammatory bowel disease: insights from a mega-analysis approach.
Stemmer E; Zahavi T; Kellerman M; Sinberger LA; Shrem G; Salmon-Divon M
Front Immunol; 2024; 15():1353402. PubMed ID: 38510241
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs as tools to predict glucocorticoid response in inflammatory bowel diseases.
De Iudicibus S; Lucafò M; Martelossi S; Pierobon C; Ventura A; Decorti G
World J Gastroenterol; 2013 Nov; 19(44):7947-54. PubMed ID: 24307788
[TBL] [Abstract][Full Text] [Related]
6. Circular RNAs in inflammatory bowel disease.
Lun J; Guo J; Yu M; Zhang H; Fang J
Front Immunol; 2023; 14():1307985. PubMed ID: 38187401
[TBL] [Abstract][Full Text] [Related]
7. Discovery of inflammatory bowel disease-associated miRNAs using a novel bipartite clustering approach.
Altaf-Ul-Amin M; Karim MB; Hu P; Ono N; Kanaya S
BMC Med Genomics; 2020 Feb; 13(Suppl 3):10. PubMed ID: 32093721
[TBL] [Abstract][Full Text] [Related]
8. The Role of Mitochondria Dysfunction in Inflammatory Bowel Diseases and Colorectal Cancer.
Kłos P; Dabravolski SA
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769108
[TBL] [Abstract][Full Text] [Related]
9. RNA interference-based nanosystems for inflammatory bowel disease therapy.
Guo J; Jiang X; Gui S
Int J Nanomedicine; 2016; 11():5287-5310. PubMed ID: 27789943
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNAs as pathophysiological regulators, therapeutic targets and novel extracellular vesicle biomarkers for the diagnosis of inflammatory bowel disease.
Heydari R; Karimi P; Meyfour A
Biomed Pharmacother; 2024 Jun; 176():116868. PubMed ID: 38850647
[TBL] [Abstract][Full Text] [Related]
11. Lnc-ing RNA to intestinal homeostasis and inflammation.
Fitzgerald KA; Shmuel-Galia L
Trends Immunol; 2024 Feb; 45(2):127-137. PubMed ID: 38220553
[TBL] [Abstract][Full Text] [Related]
12. Refining nanoprobes for monitoring of inflammatory bowel disease.
Yao R; Zhu M; Guo Z; Shen J
Acta Biomater; 2024 Mar; 177():37-49. PubMed ID: 38364928
[TBL] [Abstract][Full Text] [Related]
13. Genetic control of autophagy underlies pathogenesis of inflammatory bowel disease.
Lassen KG; Xavier RJ
Mucosal Immunol; 2017 May; 10(3):589-597. PubMed ID: 28327616
[TBL] [Abstract][Full Text] [Related]
14. New AI model for neoplasia detection and characterisation in inflammatory bowel disease.
Abdelrahim M; Siggens K; Iwadate Y; Maeda N; Htet H; Bhandari P
Gut; 2024 Apr; 73(5):725-728. PubMed ID: 38395438
[No Abstract] [Full Text] [Related]
15. The Pivotal 'P's of inflammatory bowel disease: Prediction and Prevention.
Yogev D; Turner D
United European Gastroenterol J; 2024 May; 12(4):423-424. PubMed ID: 38165652
[No Abstract] [Full Text] [Related]
16. Connecting inflammatory bowel and neurodegenerative diseases: microRNAs as a shared therapeutic intervention.
Monaghan TM; Ugun-Klusek A; Finelli M; Gurnani P; Chakrabarti L; Kao D; Alexander C; Polytarchou C
Gut; 2024 May; 73(6):1034-1036. PubMed ID: 37137683
[No Abstract] [Full Text] [Related]
17. Author's reply: Assessing disease severity in inflammatory bowel disease - Can we reliably encompass the full disease burden?
Yun Q; Ren M
Dig Liver Dis; 2024 May; 56(5):907-908. PubMed ID: 38350763
[No Abstract] [Full Text] [Related]
18. Beyond Discrimination: A Call for Comprehensive Assessment of Clinical Prediction Models in Inflammatory Bowel Disease.
Alsoud D; Van Calster B
Inflamm Bowel Dis; 2024 Jun; 30(6):1050-1051. PubMed ID: 38460148
[No Abstract] [Full Text] [Related]
19. Reply to: Beyond Discrimination: A Call for Comprehensive Assessment of Clinical Prediction Models in Inflammatory Bowel Disease.
Famutimi D; Alayo QA; Deepak P
Inflamm Bowel Dis; 2024 Jun; 30(6):1052. PubMed ID: 38457529
[No Abstract] [Full Text] [Related]
20. Expression and Localization of miR-21 and miR-126 in Mucosal Tissue from Patients with Inflammatory Bowel Disease.
Thorlacius-Ussing G; Schnack Nielsen B; Andersen V; Holmstrøm K; Pedersen AE
Inflamm Bowel Dis; 2017 May; 23(5):739-752. PubMed ID: 28426456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
